Biobeat

Petah Tikva, Israel Founded: 2014 • Age: 12 yrs
Body vitals are monitored non-invasively through wearable devices.
Request Access

About Biobeat

Biobeat is a company based in Petah Tikva (Israel) founded in 2014 by Johanan May.. Biobeat has raised $51 million across 3 funding rounds from investors including European Union, Ally Bridge Group and Orbimed. Biobeat offers products and services including Cuff-less Blood Pressure Patch, In-Hospital Monitoring System, and Hospital at Home Solution. Biobeat operates in a competitive market with competitors including Withings, Ultrahuman, Tyto Care, iHealth Labs and Oura, among others.

  • Headquarter Petah Tikva, Israel
  • Founders Johanan May
  • Sectors
    Healthcare
    Technology
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Health Technology & Digital Health
Healthcare → Health Technology & Digital Health
Technology → Extended, Virtual & Augmented Reality
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $51 M (USD)

    in 3 rounds

  • Latest Funding Round
    $50 M (USD), Series B

    Dec 30, 2025

  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Biobeat

Biobeat offers a comprehensive portfolio of products and services, including Cuff-less Blood Pressure Patch, In-Hospital Monitoring System, and Hospital at Home Solution. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Wireless chest patch for continuous 24-hour blood pressure tracking and hypertension detection.

Integrated system for real-time vital signs monitoring in clinical settings.

Wireless tools for home-based blood pressure and health monitoring services.

People of Biobeat
Headcount 10-50
Employee Profiles 21
Employee Profiles
People
Lidor Amitay
Software Engineer
People
Daniel Hay
Mobile Application Developer
People
Tom Gelvan
Embedded Software Engineer
People
Sharon Dayan
VP Marketing

Unlock access to complete

Funding Insights of Biobeat

Biobeat has successfully raised a total of $51M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $50 million completed in December 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 3
  • Last Round Series B — $50.0M
  • First Round

    (01 Jun 2016)

  • Investors Count 4
Date Amount Transaction Name Valuation Lead Investors Investors
Dec, 2025 Amount Series B - Biobeat Valuation Ally Bridge Group , Orbimed
Oct, 2019 Amount Grant - Biobeat Valuation

investors

Jun, 2016 Amount Angel Round - Biobeat Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Biobeat

Biobeat has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include European Union, Ally Bridge Group and Orbimed. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
-
Founded Year Domain Location
-
Founded Year Domain Location
-
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Biobeat

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Biobeat

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Biobeat Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Biobeat

Biobeat operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Withings, Ultrahuman, Tyto Care, iHealth Labs and Oura, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Connected devices for health, sleep, and activity monitoring are developed.
domain founded_year HQ Location
Metabolic health is tracked via devices and fitness platforms.
domain founded_year HQ Location
Medical consultations are facilitated via self-exams and remote diagnostic devices.
domain founded_year HQ Location
Personal healthcare devices for vital monitoring are designed and produced.
domain founded_year HQ Location
Health-tracking smart rings and biosensors are developed for biometric monitoring.
domain founded_year HQ Location
Medical devices for structural heart disease are developed and provided.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Biobeat

Frequently Asked Questions about Biobeat

When was Biobeat founded?

Biobeat was founded in 2014 and raised its 1st funding round 2 years after it was founded.

Where is Biobeat located?

Biobeat is headquartered in Petah Tikva, Israel. It is registered at Petah Tikva, Central District, Israel.

Is Biobeat a funded company?

Biobeat is a funded company, having raised a total of $51M across 3 funding rounds to date. The company's 1st funding round was a Angel Round of $1M, raised on Jun 01, 2016.

What does Biobeat do?

Biobeat offers a non-invasive body vitals monitoring wearable solution. It uses reflective Pulse Oximetry technology with their algorithm to allow for constant measurements of related body vitals. Sensor delivers a range of body vitals measurement including consciousness, saturation, pulse, temperature and perspiration. The devices are connected to a mobile app or a central monitoring system where the users data is stored. Data is then compared against a persons normal levels to identify life-threatening situations. It also allows data sharing with doctors and caregivers. They have released their products for athletes and Hospitals. Founded by Arik Ben Ishai Director of startups in the Rocket and Space Department of the Ministry of Defense, Israel.

Who are the top competitors of Biobeat?

Biobeat's top competitors include Withings, Ultrahuman and Oura.

What products or services does Biobeat offer?

Biobeat offers Cuff-less Blood Pressure Patch, In-Hospital Monitoring System, and Hospital at Home Solution.

Who are Biobeat's investors?

Biobeat has 4 investors. Key investors include European Union, Ally Bridge Group, Orbimed, and Elevage Medical Technologies.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available